The Effect of Finasteride on Prostate Specific Antigen: Review of Available Data

The meaning and use of the area under a receiver operating characteristic (ROC) curve.

1982 • 20,275 citations

Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate

1987 • 2,447 citations

STUDIES ON PROSTATIC CANCER

1941 • 1,498 citations

Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the Prostate

1991 • 1,273 citations

Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges

1993 • 1,118 citations

The Effect of Finasteride in Men with Benign Prostatic Hyperplasia

1992 • 1,111 citations

Longitudinal Evaluation of Prostate-Specific Antigen Levels in Men With and Without Prostate Disease

1992 • 1,065 citations

A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer.

1991 • 954 citations

Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. II. Radical Prostatectomy Treated Patients

1989 • 877 citations

Prostate Specific Antigen Density: A Means of Distinguishing Benign Prostatic Hypertrophy and Prostate Cancer

1992 • 749 citations

A Prospective Evaluation of Plasma Prostate-Specific Antigen for Detection of Prostatic Cancer

1995 • 735 citations

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

1992 • 306 citations

Is Prostate Specific Antigen of Clinical Importance in Evaluating Outcome after Radical Prostatectomy

1993 • 240 citations

Prostate Specific Antigen and Local Recurrence after Radical Prostatectomy

1990 • 239 citations

Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasia

1994 • 210 citations

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer

1995 • 206 citations

Benign and Malignant Neoplasms of the Prostate

1993 • 203 citations

Relationship between Prostate Specific Antigen, Prostate Volume and Age in the Benign Prostate

1993 • 175 citations

The effect of finasteride on prostate‐specific antigen in men with benign prostatic hyperplasia

1993 • 133 citations

Prostate Specific Antigen Levels in Men Older than 50 Years without Clinical Evidence of Prostatic Carcinoma

1993 • 128 citations

Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Investigate the Effect of Finasteride (MK-906) on Stage D Prostate Cancer

1992 • 124 citations

Treatment with finasteride following radical prostatectomy for prostate cancer

1995 • 121 citations

Significance of different molecular forms of serum PSA. The free, noncomplexed form of PSA versus that complexed to alpha 1-antichymotrypsin.

1993 • 106 citations

Effect of finasteride on serum PSA concentration in men with benign prostatic hyperplasia. Results from the North American phase III clinical trial.

1993 • 86 citations

SIGNIFICANCE OF DIFFERENT MOLECULAR FORMS OF SERUM PSA

1993 • 73 citations

New Methods of Endocrine Management of Prostatic Cancer

1987 • 71 citations

Detection of Local Recurrence After Radical Prostatectomy by Prostate Specific Antigen and Transrectal Ultrasound

1992 • 65 citations

The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications

1986 • 59 citations

Maintenance of Clinical Efficacy With Finasteride Therapy for 24 Months in Patients With Benign Prostatic Hyperplasia

1994 • 55 citations

Effect of finasteride on prostate-specific antigen density

1994 • 43 citations

Endocrine dependence of prostatic cancer upon dihydrotestosterone and not upon testosterone

1984 • 36 citations

5Alpha-reductase inhibitors and the treatment of benign prostatic hyperplasia

1993 • 13 citations

Treatment of Benign Prostatic Hyperplasia with 5α-Reductase Inhibitors

1995 • 9 citations

Maintenance of clinical efficacy with finasteride therapy for 24 months in patients with benign prostatic hyperplasia. The Finasteride Study Group

1994 • 8 citations